Inventor · disambiguated record
George Avgerinos
Also filed as: AVGERINOS GEORGE · AVGERINOS GEORGE C · AVGERINOS GEORGE COSTAS
19 granted patents·9 pending applications·720 citations·filing 1981–2024
96Inventor score
Top patents by PatentIndex Score
28 records- 0198US8916153B2Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2013·Granted Dec 23, 2014·48 cites·14 claims
- 0298US8883156B2Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2013·Granted Nov 11, 2014·46 cites·19 claims
- 0398US7863426B2Antibody purificationABBOTT BIOTECH LTD·Filed 2007·Granted Jan 4, 2011·211 cites·64 claims
- 0497US9328165B2Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted May 3, 2016·20 cites·30 claims
- 0597US9273132B2Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Mar 1, 2016·19 cites·26 claims
- 0697US9102723B2Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Aug 11, 2015·31 cites·28 claims
- 0797US8906372B2Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2013·Granted Dec 9, 2014·45 cites·19 claims
- 0897US8895009B2Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2013·Granted Nov 25, 2014·46 cites·13 claims
- 0996US9096666B2Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Aug 4, 2015·23 cites·30 claims
- 1096US8231876B2Purified antibody compositionWAN MIN M·Filed 2010·Granted Jul 31, 2012·109 cites·13 claims
- 1194US7491516B2Dual specificity antibodies and methods of making and usingABBOTT LAB·Filed 2001·Granted Feb 17, 2009·66 cites·25 claims
- 1292US11965032B1Anti-CD20 antibody compositionsTG THERAPEUTICS INC·Filed 2023·Granted Apr 23, 2024·2 cites·18 claims
- 1391US11884740B1Anti-CD20 antibody compositionsTG THERAPEUTICS INC·Filed 2022·Granted Jan 30, 2024·2 cites·15 claims
- 1491US11807689B1Anti-CD20 antibody compositionsTG THERAPEUTICS INC·Filed 2022·Granted Nov 7, 2023·2 cites·22 claims
- 1591US4395543ASelective solvent extraction of cellulosic materialMASSACHUSETTS INST TECHNOLOGY·Filed 1981·Granted Jul 26, 1983·43 cites·10 claims
- 1689US11814439B1Anti-CD20 antibody compositionsTG THERAPEUTICS INC·Filed 2022·Granted Nov 14, 2023·2 cites·19 claims
- 1787US11083792B2Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2018·Granted Aug 10, 2021·1 cites·22 claims
- 1886US9913902B2Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2017·Granted Mar 13, 2018·2 cites·19 claims
- 1982US2022339284A1Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2021·Application pending·0 cites
- 2079US2021260186A1Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2021·Application pending·0 cites
- 2177US2024209110A1Anti-cd20 antibody compositionsTG THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2277US2024270863A1Anti-cd20 antibody compositionsTG THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2375US8475766B2Dual specificity antibodies and methods of making and usingCOLLINSON ALBERT·Filed 2008·Granted Jul 2, 2013·2 cites·23 claims
- 2465US2017136122A1Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2016·Application pending·0 cites
- 2564US2013028903A1Purified antibody compositionWAN MIN·Filed 2012·Application pending·0 cites
- 2662US2014378666A1Dual specificity antibodies and methods of making and usingABBVIE INC·Filed 2014·Application pending·0 cites
- 2759US2014155579A1Dual specificity antibodies and methods of making and usingABBVIE INC·Filed 2013·Application pending·0 cites
- 2852US2015175694A1Dual specificity antibodies and methods of making and usingABBVIE INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →